Table 3.
Summary of studies on expression and purification of recombinant tau.
| Study | Tau isoform or construct studied | Purification method used | Yield | Purity |
|---|---|---|---|---|
| This work | Wild type K18 and its N279K and V337M frontotemporal dementia variants | Ni2+ affinity chromatography | Up to ∼5.5 mg/ml, 4.0 mg/ml and 3.5 mg/ml protein per 500 ml culture for K18 WT, K18 V337M and K18 N279K respectively | Up to 99% purity for monomer only and 95% for monomer-oligomer mix |
| Tepper et al. (2014) [39] | 2N4R (longest tau isoform in the adult human brain) | Tau expressed in Sf9 cells was purified by size exclusion and anion exchange chromatography | 5–10 μM (subsequently concentrated to ∼50 μM) | Not indicated |
| Geodert and Jakes (1990) [23] | The six human tau isoforms | Ammonium sulphate precipitation and ion exchange chromatography | 30–60 μg/ml culture | Up to 95% purity |
| Barghorn et al. (2005) [13] | Tau isoforms and constructs including K18 | Gel permeation and cation exchange chromatography | 10–100 mg protein/10 L culture (specific concentration for K18 not indicated) |
95% for monomer-oligomer mixtures and 99% for monomer only |
| Csokova et al. (2004) [17] | 221-441 fragment of tau | Cation exchange, anion exchange and size exclusion chromatography | 4–8 mg protein/500 ml culture | Up to 98% purity |